1. McWilliams*, JA, RT Sullivan*, KR Jordan*, RH McMahan*, CB Kemmler*, M McDuffie, JE Slansky. T cell tolerance to an endogenous retrovirus-encoded tumor-associated antigen increases with age. Vaccine 26:1863-1873 (2008) [*equal contributors].
2. Jordan KR, RH McMahan, JZ Oh, MR Pipeling, DM Pardoll, RM Kedl, JW Kappler, JE Slansky. Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity. J Immunol 180:188-197 (2008).
3. McMahan RH and JE Slansky. Mobilizing the low-avidity T cell repertoire to kill tumors. Sem Cancer Biol 17:317-329 (2007).
4. McMahan RH, JA McWilliams, KR Jordan, SW Dow, DB Wilson, JE Slansky. Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. J Clin Invest 116:2543-2551 (2006).
E. Hutchinson, Everything in Moderation, Nature Reviews Cancer Research Highlights 6:747 (2006).
5. McWilliams JA, SM McGurran, SW Dow, JE Slansky, RM Kedl. A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model. J Immunol 177:155-161 (2006).
6. Crawford F, KR Jordan, B Stadinski, Y Wang, E Huseby, P Marrack, JE Slansky, JW Kappler. Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands. Immunol Rev 210:156-170 (2006).
Recent Publications
